IMPACCT: RWE is taking place in Boston, MA on September 25-27 2018, and is the only meeting dedicated to supporting drug developers in making real-world evidence-based decisions, from clinical development to commercialization of their products.

Attend this meeting and benefit from:

• Case-Study Led Content
  We know the value of case-study led discussions. That’s why at the IMPACCT:RWE Summit we’ve tailor-made an agenda that contains over eighteen case studies around how real-world evidence is currently being applied across the drug development continuum to support decision-making in clinical development, drug marketing and commercialization, and how you can define and develop a comprehensive evidence generation plan that supports activities from clinical to commercial. You will have a chance to discuss with peers and learn from thought leaders in the industry such as Lundbeck, Biogen, BMS, Amgen, GSK, Pfizer and more.
• Meet and Network with Industry Pioneers
  With a room full of senior drug development and commercialization professionals striving to effectively leverage real-world evidence to benefit patients, this summit is your chance to meet like-minded industry peers to shape the future of RWE together.
• Pre-Conference Workshop Session
  In a highly engaging and interactive discussion, you will learn decision science basics, including implementation examples. The group will also explore opportunities and strategies for RWE to leverage decision science as a vehicle to achieve greater value by informing and helping to change drug development and commercial decision making within your organization.

To learn more about this event, visit http://bit.ly/2OP3kMW